Document is current
Any future updates will be listed below
-
Authors
Itaya, Takahiro
Torii, Mie
Hashimoto, Motomu https://orcid.org/0000-0002-9241-060X
Jindai, Kazuaki
Yamamoto, Wataru
Tanigawa, Kyosuke
Urai, Yuki
Kinoshita, Ayae
Nin, Kazuko
Watanabe, Ryu
Murata, Koichi
Murakami, Kosaku
Tanaka, Masao
Ito, Hiromu
Matsuda, Shuichi
Morinobu, Akio
- License Information
-
More Information
Article History
Received: 10 February 2021
Revised: 28 May 2021
Accepted: 21 June 2021
First Online: 28 September 2021
Declarations
:
: The Ethical Review Board at Kyoto University Graduate School and Faculty of Medicine Kyoto University Hospital Ethics Committee, Kyoto, Japan, approved the study (approval number: R0357).
: All participants provided informed consent.
: Department of Advanced Medicine for Rheumatic Diseases is supported by Nagahama City, Shiga, Japan, Toyooka City, Hyogo, Japan and five pharmaceutical companies (Mitsubishi Tanabe Pharma Co., Chugai Pharmaceutical Co. Ltd, UCB Japan Co. Ltd, AYUMI Pharmaceutical Co. and Asahi Kasei Pharma Corp.). MH received a research grant and/or speaker fee from Bristol-Myers, Eisai, Eli Lilly and Mitsubishi Tanabe Pharma. RW received speaker’s fee from Mitsubishi Tanabe Pharma, Pfizer, Sanofi, AbbVie, Asahi Kasei, Eisai, Eli Lilly, Bristol-Myers Squibb and Janssen. KMurat received speaker fees from Eisai Co., Ltd. MTa received research grants and/or speaker fees from AbbVie GK, Asahi Kasei Pharma Corp., Astellas Pharma Inc., Ayumi Pharmaceutical Corp., Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Pfizer Inc., UCB Japan Co., Ltd., Janssen Pharmaceutical K.K., Mitsubishi Tanabe Pharma Corp., Novartis Pharma K.K., Taisho Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd. HI received research grants and/or speaker fees from BMS, Kyocera, Asahi-Kasei, Eisai, Mochida and Toyama. SM received research grants and/or speaker fees from AYUMI Pharmaceutical Co., Pfizer Inc., Eli Lilly Japan K.K., Mitsubishi Tanabe Pharma Corp., Kyocera, Chugai Pharmaceutical Co. Ltd., Mochida and Taisho Pharma Co., Ltd. AM received speaking fees and/or research grants from Eli Lilly Japan K.K., Ono Pharmaceutical Co., Pfizer Inc., UCB Japan, AbbVie G.K., Asahi Kasei Pharma and Chugai Pharmaceutical Co. Ltd. TI, MTo, WY, KT, YU, AK, KN, KJ and KMurak have declared no conflicts of interest.
Free to read: This content has been made available to all.
